Researchers pinpoint where smallpox outbreak would hit hardest

March 2, 2018, University of New South Wales
Researchers pinpoint where smallpox outbreak would hit hardest
The variola virus (smallpox). Credit: Shutterstock

The ease of creating a smallpox-like virus, and the growing number of vulnerable people with weakened immune systems, present challenges for emergency response planners, researchers have warned.

Unprecedented levels of immunosuppression in countries such as Australia and the US must be considered in planning for the real risk of smallpox re-emerging in the world, an expert in warned.

"Smallpox was eradicated in 1980 but in 2017 Canadian scientists created a smallpox-like virus in a lab using just mail-order DNA," said UNSW Professor of Infectious Disease Epidemiology Raina MacIntyre. "In 2018, these same scientists published a step-by-step method to create a pox virus in a lab, making the threat of smallpox re-emergence even greater.

"Experts have long feared this scenario, and it is now a reality.

"This highlights the real risk of smallpox re-emerging in the world, without terrorists needing to access closely guarded stockpiles of the virus," said Professor MacIntyre, who is also Director of the NHMRC Centre for Research Excellence, Integrated Systems for Epidemic Response.

In the nearly 40 years since smallpox was eradicated, much has changed in society. Advances in medicine mean that many more people today – such as people with HIV, and people being treated for cancer and autoimmune conditions – live with a weakened immune system.

Research led by Professor MacIntyre published in the US Centers for Disease Control and Prevention journal Emerging Infectious Diseases used a mathematical model to identify the impact of smallpox re-emerging in cities such as Sydney and New York, and identified that the highest rates of smallpox infection would be in people aged under 20 years, but the highest death rates would be among people aged 45 and over. Almost one in five people in cities like Sydney and New York have a weakened immune system, which would make the impact of an attack with smallpox much more severe, the study says.

"The rates of immunosuppression were even higher for the age group 60-65 years, because of natural decline of the immune system with age. We have an ageing population, and this must be considered when planning for a bioterrorism attack, and vaccination strategies during an outbreak," Professor MacIntyre said.

The study is also a tale of two cities with very different vaccination policies. Smallpox vaccine was routine in New York, but not used widely in Sydney. Professor MacIntyre said almost 22% of the New York population was vaccinated for smallpox, compared with only 10% of the Sydney population – and these people were mostly migrants vaccinated in their country of origin.

The modelling found that despite widespread past vaccination in New York, the impact of smallpox in this city would be more serious than in Sydney due to New York's larger number of immunosuppressed people.

Immunologist and HIV expert Professor Tony Kelleher, from the Kirby Institute, said that "immunosuppression would likely drive the impact of smallpox more than past vaccination, especially with so many people today living with HIV, or receiving cancer therapy or other medical treatments that suppress the immune system".

"Vaccine immunity wanes over time, and recent vaccination is needed for protection. The good news is, people who have been vaccinated in the past would have a faster response to re-vaccination in the event of an outbreak," Professor MacIntyre said. "The bad news is, both cities show the highest smallpox infection rates for unvaccinated young people, aged 5 to 20 years."

The study also notes the importance of vaccination for health workers, and the need for hospitals to have appropriate isolation facilities to minimise a outbreak.

Explore further: Smallpox vaccine study yields favorable results

More information: C. Raina MacIntyre et al. Influence of Population Immunosuppression and Past Vaccination on Smallpox Reemergence, Emerging Infectious Diseases (2018). DOI: 10.3201/eid2404.171233

Related Stories

Smallpox vaccine study yields favorable results

February 7, 2018
Officials from Bavarian Nordic yesterday announced the results of a successful Phase 3 clinical trial led by USAMRIID that demonstrated the safety and efficacy of the company's investigational, non-replicating smallpox vaccine, ...

Man who got smallpox vaccine passes milder infection to sex partner

February 28, 2013
(HealthDay)—A man recently vaccinated for smallpox under a U.S. Defense Department program passed a milder, related form of the disease on to a man he had sex with, and that man then passed it on to yet another man, federal ...

Why does smallpox vaccine shield some, not others? It's in the genes, study finds

April 18, 2013
How well people are protected by the smallpox vaccine depends on more than the quality of the vaccination: individual genes can alter their response, Mayo Clinic research shows. The findings, gathered using sophisticated ...

Professor calls for total destruction of smallpox samples

May 23, 2014
Smallpox, the only viral disease to be completely eradicated globally, is hitting the headlines this week as health ministers from around the world decide whether the last two remaining laboratory samples should be destroyed.

Recommended for you

Collaboration yields possible treatment for rare neurodegenerative disorder

October 23, 2018
St. Jude Children's Research Hospital investigators have developed a new class of compounds that extended the lives and eased symptoms of mice with a progressive neurodegenerative human disorder. The findings appear today ...

Genetic flaw causes problems for many with hypothyroidism

October 23, 2018
With an estimated 120 million prescriptions filled each year, the thyroid medicine levothyroxine (marketed as Synthroid ) is one of the most popular prescription medicines in the United States. Most patients who suffer from ...

'Game changer' tuberculosis drug cures 9 in 10

October 22, 2018
A new treatment for a drug-resistant strain of tuberculosis can cure more than 90 percent of sufferers, according to a trial hailed Monday as a "game changer" in the fight against the global killer.

Consuming caffeine from coffee reduces incident rosacea

October 22, 2018
(HealthDay)—Caffeine intake from coffee is inversely associated with the risk for incident rosacea, according to a study published online Oct. 17 in JAMA Dermatology.

AI doctor could boost chance of survival for sepsis patients

October 22, 2018
Scientists have created an artificial intelligence system that could help treat patients with sepsis.

Home-based biofeedback therapy is effective option for tough-to-treat constipation

October 22, 2018
Biofeedback therapy used at home is about 70 percent effective at helping patients learn how to coordinate and relax bowel muscles and relieve one of the most difficult-to-treat types of constipation, investigators report.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.